Auto saved by Logseq

master
FMS 9 months ago
parent 41cd5b1da5
commit e2fc32ed98

@ -71,6 +71,7 @@
- PL: The work being done by Sanger is it full genome analysis?
- AK: sí. su approach también es ese para este proyecto.
- JOHN AMUASI: really a rich presentation of the clinical data. Quite a significant variation in the AE.
- AK: We did find larger number of individuals with AE. it was expected. All mild and moderate severity, all self limiting. Non of the participants in the FDC3 had to stop and not take all the doses.
-
-
- ## Cosas de gastos del [[Evento]]

Loading…
Cancel
Save